Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.
about
Elevation of Peripheral BDNF Promoter Methylation Predicts Conversion from Amnestic Mild Cognitive Impairment to Alzheimer's Disease: A 5-Year Longitudinal Study.CircRNA_100269 is downregulated in gastric cancer and suppresses tumor cell growth by targeting miR-630.Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy.Identification and evolution of latrophilin receptor gene involved in Tribolium castaneum devolopment and female fecundity.Pharmacogenetics of response to neoadjuvant paclitaxel treatment for locally advanced breast cancer.Pharmacoepigenetics and pharmacoepigenomics of gastrointestinal cancers.
P2860
Aberrant Epigenetic Modifications of LPHN2 Function as a Potential Cisplatin-Specific Biomarker for Human Gastrointestinal Cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aberrant Epigenetic Modificati ...... Human Gastrointestinal Cancer.
@en
type
label
Aberrant Epigenetic Modificati ...... Human Gastrointestinal Cancer.
@en
prefLabel
Aberrant Epigenetic Modificati ...... Human Gastrointestinal Cancer.
@en
P2093
P2860
P356
P1476
Aberrant Epigenetic Modificati ...... Human Gastrointestinal Cancer.
@en
P2093
Hwang-Phill Kim
Jee-Youn Kang
Jiyeon Yun
Mi-Seong Jeon
Sae-Won Han
Sang-Hyun Song
Tae-You Kim
P2860
P304
P356
10.4143/CRT.2015.153
P577
2015-09-22T00:00:00Z